SCHEMBL754864

SCHEMBL754864

Cc1cc2sc3cc4c(cc3c2cc1C)sc1cc2ccccc2cc14

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 5/20 0.36
CYP1A2 P05177 4/20 0.36
NQO1 P15559 1/20 0.36
ALDH1A1 P00352 8/20 0.35
TDP1 Q9NUW8 1/20 0.35
GAA P10253 3/20 0.35
MAPT P10636 4/20 0.35
MEN1 O00255 1/20 0.35
POLB P06746 1/20 0.35
KMT2A Q03164 1/20 0.35
GPR3 P46089 1/20 0.34
NQO2 P16083 1/20 0.34
SMN1; SMN2 Q16637 3/20 0.33
HPGD P15428 3/20 0.33
TSHR P16473 2/20 0.33
RAB9A P51151 2/20 0.33
TP53 P04637 1/20 0.33
CYP3A4 P08684 1/20 0.33
ELANE P08246 1/20 0.33
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL754841 0.96 CYP2A6 (0.34) CYP2A6CYP1A2NQO1ALDH1A1TDP1
SCHEMBL20342326 0.90 CYP2A6 (0.38) CYP2A6CYP1A2NQO1ALDH1A1TDP1
SCHEMBL752667 0.87 GPR3 (0.43) CYP2A6NQO1ALDH1A1TDP1GAA
SCHEMBL11990859 0.85 GPR3 (0.46) CYP2A6CYP1A2NQO1ALDH1A1TDP1
SCHEMBL30888167 0.85 GPR3 (0.46) CYP2A6CYP1A2NQO1ALDH1A1TDP1
SCHEMBL754840 0.83 GPR3 (0.40) CYP2A6NQO1ALDH1A1TDP1GAA
SCHEMBL16024612 0.83 GPR3 (0.43) CYP2A6NQO1ALDH1A1TDP1MAPT
SCHEMBL23743698 0.81 CYP2A6 (0.57) CYP2A6CYP1A2NQO1ALDH1A1TDP1
SCHEMBL753463 0.81 GAA (0.37) ALDH1A1GAAMAPTSMN1; SMN2HPGD
SCHEMBL13250620 0.81 GPR3 (0.42) CYP2A6NQO1ALDH1A1TDP1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138355-B2 Heteroacene derivative, tetrahaloterphenyl derivative, and processes for producing the same TOSOH CORPORATION (JP) 2012-03-20 US disclosed
US-20090261300-A1 HETEROACENE DERIVATIVE, TETRAHALOTERPHENYL DERIVATIVE, AND PROCESSES FOR PRODUCING THE SAME TOSOH CORPORATION (JP) 2009-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090261300-A1 HETEROACENE DERIVATIVE, TETRAHALOTERPHENYL DERIVATIVE, AND PROCESSES FOR PRODUCING THE SAME AS3MT, TERT, TEAD1 CYP2A6 880/4885CYP1A2 340/4885NQO1 3530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.